Evaluating a digital tool for supporting breast cancer patients: a randomized controlled trial protocol (ADAPT)
Lidington et al., 2020; BMC. OWise is being assessed by the randomised clinical trial ADAPT at the Royal Marsden NHS Foundation Trust. Find out more here:
Evaluating mobile applications for Breast Cancer in Germany: A systematic review
A systematic review that evaluated if breast cancer apps can support patients, whereby the OWise app received the highest score.
Patients’ and Health Care Providers’ Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation
Young-Afat et al., 2016; JMIR Cancer. Independent study analysed OWise app. Read more to know what the study found!